Skip to main content

Applied Biosystems, Parallel Synthesis Technologies


The new expression analysis system launched by Applied Biosystems will be marketed as the Applied Biosystems 1700 Chemiluminescent Microarray Analyzer. The product will sell at a list price of $177,000, according to the company. The company’s initial product for this platform, a whole-human-genome single microarray, will list for $890.

Parallel Synthesis Technologies of Santa Clara, Calif., this week introduced its Silicon Microarray contact printing technology for spotting DNA and protein microarrays. The four-year-old company machines its spotting pins from single-crystal silicon wafers using semiconductor-manufacturing techniques. The product line can spot directly from a 1,536-well source plate, and can print with 192 pins simultaneously, performing 400 spots per fill of 100 nanoliters. Print tip sizes range from 50x50 to 200x200 microns enabling the creation of spots ranging from 75 to 250 micrometers in diameter. The company has successfully test- printed materials such as proteins, lipids, and whole cell lysates.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.